207 related articles for article (PubMed ID: 6800996)
1. Trioxacarcins, novel antitumor antibiotics. II. Isolation, physico-chemical properties and mode of action.
Tamaoki T; Shirahata K; Iida T; Tomita F
J Antibiot (Tokyo); 1981 Dec; 34(12):1525-30. PubMed ID: 6800996
[No Abstract] [Full Text] [Related]
2. Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.
Balitz DM; O'Herron FA; Bush J; Vyas DM; Nettleton DE; Grulich RE; Bradner WT; Doyle TW; Arnold E; Clardy J
J Antibiot (Tokyo); 1981 Dec; 34(12):1544-55. PubMed ID: 7344705
[No Abstract] [Full Text] [Related]
3. Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.
Tamaoki T; Kasai M; Shirahata K; Ohkubo S; Morimoto M; Mineura K; Ishii S; Tomita F
J Antibiot (Tokyo); 1980 Sep; 33(9):946-50. PubMed ID: 6160139
[TBL] [Abstract][Full Text] [Related]
4. Trioxacarcins, novel antitumor antibiotics. I. Producing organism, fermentation and biological activities.
Tomita F; Tamaoki T; Morimoto M; Fujimoto K
J Antibiot (Tokyo); 1981 Dec; 34(12):1519-24. PubMed ID: 6895890
[No Abstract] [Full Text] [Related]
5. Hydroxychlorothricin, a new antitumor antibiotic.
Yamamoto I; Nakagawa M; Hayakawa Y; Adachi K; Kobayashi E
J Antibiot (Tokyo); 1987 Oct; 40(10):1452-4. PubMed ID: 3680011
[No Abstract] [Full Text] [Related]
6. Ankinomycin, a potent antitumor antibiotic.
Sato Y; Watabe H; Nakazawa T; Shomura T; Yamamoto H; Sezaki M; Kondo S
J Antibiot (Tokyo); 1989 Jan; 42(1):149-52. PubMed ID: 2590276
[No Abstract] [Full Text] [Related]
7. Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.
Nakano H; Matsuda Y; Ito K; Ohkubo S; Morimoto M; Tomita F
J Antibiot (Tokyo); 1981 Mar; 34(3):266-70. PubMed ID: 7275807
[TBL] [Abstract][Full Text] [Related]
8. Isolation and structure elucidation of vicenistatin M, and importance of the vicenisamine aminosugar for exerting cytotoxicity of vicenistatin.
Matsushima Y; Nakayama T; Fujita M; Bhandari R; Eguchi T; Shindo K; Kakinuma K
J Antibiot (Tokyo); 2001 Mar; 54(3):211-9. PubMed ID: 11372778
[TBL] [Abstract][Full Text] [Related]
9. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527
[TBL] [Abstract][Full Text] [Related]
10. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties.
Otani T; Minami Y; Marunaka T; Zhang R; Xie MY
J Antibiot (Tokyo); 1988 Nov; 41(11):1580-5. PubMed ID: 3198492
[TBL] [Abstract][Full Text] [Related]
11. Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation.
Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
J Antibiot (Tokyo); 1993 Oct; 46(10):1536-49. PubMed ID: 8244881
[TBL] [Abstract][Full Text] [Related]
12. Gilvocarcins, new antitumor antibiotics. 4. Mode of action.
Tomita F; Takahashi K; Tamaoki T
J Antibiot (Tokyo); 1982 Aug; 35(8):1038-41. PubMed ID: 6815145
[TBL] [Abstract][Full Text] [Related]
13. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y
J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440
[No Abstract] [Full Text] [Related]
14. Metabolic products of microorganisms. 234. Urdamycins, new angucycline antibiotics from Streptomyces fradiae. I. Isolation, characterization and biological properties.
Drautz H; Zähner H; Rohr J; Zeeck A
J Antibiot (Tokyo); 1986 Dec; 39(12):1657-69. PubMed ID: 3818439
[TBL] [Abstract][Full Text] [Related]
15. New antitumor substances, BE-12406A and BE-12406B, produced by a streptomycete. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties.
Kojiri K; Arakawa H; Satoh F; Kawamura K; Okura A; Suda H; Okanishi M
J Antibiot (Tokyo); 1991 Oct; 44(10):1054-60. PubMed ID: 1955386
[TBL] [Abstract][Full Text] [Related]
16. PD 118,576: a new antitumor macrolide antibiotic.
Wilton JH; Hokanson GC; French JC
J Antibiot (Tokyo); 1985 Nov; 38(11):1449-52. PubMed ID: 3841121
[TBL] [Abstract][Full Text] [Related]
17. Senacarcin A, a new antitumor antibiotic produced by Streptomyces endus subsp. aureus.
Nakano H; Yoshida M; Shirahata K; Ishii S; Arai Y; Morimoto M; Tomita F
J Antibiot (Tokyo); 1982 Jun; 35(6):760-2. PubMed ID: 7118728
[No Abstract] [Full Text] [Related]
18. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44.
Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M
J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049
[No Abstract] [Full Text] [Related]
19. A new antitumor antibiotic product, demethylchartreusin. Isolation and biological activities.
Aoyama Y; Katayama T; Yamamoto M; Tanaka H; Kon K
J Antibiot (Tokyo); 1992 Jun; 45(6):875-8. PubMed ID: 1500353
[TBL] [Abstract][Full Text] [Related]
20. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties.
Ueki M; Ueno K; Miyadoh S; Abe K; Shibata K; Taniguchi M; Oi S
J Antibiot (Tokyo); 1993 Jul; 46(7):1089-94. PubMed ID: 8360104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
